Free Trial Information
BioCentury | Apr 15, 2013
Clinical News

Penederm regulatory update

...approval in other European countries. DERM plans to begin U.S. marketing in the third quarter. Penederm Inc....
Read More
BioCentury | Apr 15, 2013
Clinical News

Penederm regulatory update

...price is $27.12 for a 15 gram tube, and $48.60 for a 30 gram tube. Penederm Inc....
Read More
BioCentury | Apr 15, 2013
Company News

Penederm, SmithKline deal

...milestone payments and royalties. DERM also will generate revenues from supplying the compounds to SmithKline. Penederm Inc....
Read More
BioCentury | Apr 15, 2013
Company News

Penederm sales and marketing update

...quarter. DERM's contract sales force will market the product to dermatologists. (DERM patent, see B6) Penederm Inc....
Read More
BioCentury | Apr 15, 2013
Company News

Penederm board of directors update

Penederm Inc. (DERM), Foster City, Calif. Business: Dermatology, Drug delivery Appointed: Director David Collins, to chairman WIR Staff Dermatology...
Read More
BioCentury | Oct 12, 1998
Company News

Penederm, Mylan Laboratories Inc. deal

...Mylan completed its acquisition of DERM (see BioCentury, June 29). Penederm Inc. (DERM), Foster City, Calif. Mylan...
Read More
BioCentury | Jul 27, 1998
Company News

Penederm, Pedinol Pharmacal Inc. sales and marketing update

...The companies will co-promote DERM's Mentax topical antifungal product to podiatrists in the U.S. Penederm Inc. (DERM...
Read More
BioCentury | Jul 13, 1998
Company News

Mylan Laboratories Inc., Penederm sales and marketing update

...prepaid co-promotion payments to DERM totaling from $1-$3 million. Mylan Laboratories Inc. (MYL), Pittsburgh, Penn. Penederm Inc....
Read More
BioCentury | Jun 29, 1998
Strategy

Get a product - get acquired

...mostly to those biotech companies with products on the market. Mylan Laboratories Inc.'s acquisition of Penederm Inc....
Read More
BioCentury | Jun 29, 1998
Company News

Penederm, Mylan Laboratories Inc. deal

...of the skin, to cosmetic companies. DERM had $2.6 million in cash on March 31. Penederm Inc....
Read More
Items per page:
1 - 10 of 62
BioCentury | Apr 15, 2013
Clinical News

Penederm regulatory update

...approval in other European countries. DERM plans to begin U.S. marketing in the third quarter. Penederm Inc....
Read More
BioCentury | Apr 15, 2013
Clinical News

Penederm regulatory update

...price is $27.12 for a 15 gram tube, and $48.60 for a 30 gram tube. Penederm Inc....
Read More
BioCentury | Apr 15, 2013
Company News

Penederm, SmithKline deal

...milestone payments and royalties. DERM also will generate revenues from supplying the compounds to SmithKline. Penederm Inc....
Read More
BioCentury | Apr 15, 2013
Company News

Penederm sales and marketing update

...quarter. DERM's contract sales force will market the product to dermatologists. (DERM patent, see B6) Penederm Inc....
Read More
BioCentury | Apr 15, 2013
Company News

Penederm board of directors update

Penederm Inc. (DERM), Foster City, Calif. Business: Dermatology, Drug delivery Appointed: Director David Collins, to chairman WIR Staff Dermatology...
Read More
BioCentury | Oct 12, 1998
Company News

Penederm, Mylan Laboratories Inc. deal

...Mylan completed its acquisition of DERM (see BioCentury, June 29). Penederm Inc. (DERM), Foster City, Calif. Mylan...
Read More
BioCentury | Jul 27, 1998
Company News

Penederm, Pedinol Pharmacal Inc. sales and marketing update

...The companies will co-promote DERM's Mentax topical antifungal product to podiatrists in the U.S. Penederm Inc. (DERM...
Read More
BioCentury | Jul 13, 1998
Company News

Mylan Laboratories Inc., Penederm sales and marketing update

...prepaid co-promotion payments to DERM totaling from $1-$3 million. Mylan Laboratories Inc. (MYL), Pittsburgh, Penn. Penederm Inc....
Read More
BioCentury | Jun 29, 1998
Strategy

Get a product - get acquired

...mostly to those biotech companies with products on the market. Mylan Laboratories Inc.'s acquisition of Penederm Inc....
Read More
BioCentury | Jun 29, 1998
Company News

Penederm, Mylan Laboratories Inc. deal

...of the skin, to cosmetic companies. DERM had $2.6 million in cash on March 31. Penederm Inc....
Read More
Items per page:
1 - 10 of 62